In this interview, Rob Trainor, the Vice President of Operations at Sphere Fluidics, sits down for an insightful conversation detailing the completion of Sphere Fluidics’ new state-of-the-art facilities and the strategic decisions behind their office move and rebranding.
Filament Health Corp. Announces Non-Brokered Private Placement Unit Offering of Up To C$2,000,000 | Psychedelic Invest
Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical‐stage natural psychedelic drug development company, today announced that it intends to complete, subject to
July 20, 2023